CONFERENCE ON ARTERIOSCLEROSIS AND VASCULAR BIOLOGY

动脉硬化、血栓形成和血管生物学会议将于2000年5月20日至22日在科罗拉多的布鲁姆菲尔德/丹佛举行，为期两天半。 本次会议旨在成为年度会议，重点关注动脉硬化（脂质和脂蛋白），血栓形成和血管生物学领域的新兴研究。 该会议由美国心脏协会动脉炎、血栓形成和血管生物学理事会主办，第一年由北美血管生物学组织共同主办。本次会议的主要目标是将动脉硬化、血栓形成和血管生物学研究界的不同学科聚集在一起，使研究人员能够交流和传播信息并探索跨学科感兴趣的领域。 这些学科长期以来一直被视为独立的实体，但实际上脂质和脂蛋白功能与血栓形成和血管壁事件交织在一起，反之亦然。 该计划旨在通过在非正式环境中检查脂质和脂蛋白，血栓形成和血管生物学的新领域和新兴领域来鼓励这些学科之间的交叉施肥。 热点话题和全体会议旨在促进跨学科的讨论和互动领域的血管生成，PPARs在动脉粥样硬化，一氧化氮功能，abc 1基因在HDL代谢，血管疾病的分子遗传学和血管壁的细胞生物学。 每个代表领域计划的特别会议，即，动脉硬化，血栓形成和血管生物学，将提供一个机会，口头介绍摘要，每次会议开始时，主题由该领域的专家给予。 动脉硬化课程涵盖了转基因和腺病毒模型领域，以研究脂蛋白代谢、动脉粥样硬化中的HDL、饮食和基因对血脂异常的影响以及动脉粥样硬化中的脂肪酶。 血栓形成会议地址蛋白C途径，整合素生物学，血小板信号传导，以及体液和细胞因子在纤溶领域。 血管生物学课程包括内皮细胞功能、平滑肌细胞病理生物学、血管自动调节和重塑以及血管疾病中的炎症。 这次会议将促进动脉硬化，血栓形成和血管生物学之间更强的联系，并为研究人员提供一个讨论新突破信息的机会。 由于在脂质和脂蛋白、血栓形成和血管生物学领域培养全面的新研究人员的重要性，一个主要目标是鼓励年轻科学家参加会议。

The Conference on Arteriosclerosis, Thrombosis and Vascular Biology is a two and one-half day meeting, May 20-22, 2000, to be held in Broomfield/Denver, Colorado. This meeting is designed to be an annual meeting that will focus on new emerging research in the areas of arteriosclerosis (lipids and lipoproteins), thrombosis and vascular biology. The meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology of the American Heart Association and in its first year is co- sponsored by the North American Vascular Biology Organization. The major goal of this conference is to bring together diverse disciplines within the Arteriosclerosis, Thrombosis and Vascular Biology research communities to allow investigators to exchange and disseminate information and to explore areas of cross- disciplinary interest. These disciplines have long been treated as separate entities yet in reality lipid and lipoprotein functions are interwoven with thrombotic and vascular wall events and vice versa. The program is designed to encourage cross- fertilization between these disciplines by examining new and emerging areas in lipids and lipoproteins, thrombosis and vascular biology in an informal setting. Hot Topics and Plenary sessions have been designed to stimulate interdisciplinary discussions and interactions in the areas angiogenesis, PPARs in atherosclerosis, nitric oxide function, abc1 gene in HDL metabolism, molecular genetics of vascular disease, and cell biology of the vessel wall. Special sessions planned by each of the representative areas, i.e., arteriosclerosis, thrombosis and vascular biology, will provide an opportunity for oral presentations of abstracts and each session begins with a keynote talk on the topic to be given by an expert in the field. The arteriosclerosis sessions cover the areas of transgenic and adenovirus models to study lipoprotein metabolism, HDL in atherosclerosis, diet and gene contribution to dyslipidemias, and lipases in atherosclerosis. The thrombosis sessions address the areas of protein C pathways, integrin biology, platelet signaling, and humoral and cellular factors in fibrinolysis. The vascular biology sessions include endothelial cell function, smooth muscle cell pathobiology, vascular autoregulation and remodeling, and inflammation in vascular disease. The conference will foster stronger links between arteriosclerosis, thrombosis and vascular biology and provide an opportunity for investigators to discuss newly breaking information. Because of the importance for developing well-rounded new investigators in the areas of lipids and lipoproteins, thrombosis and vascular biology, a major objective is to encourage young scientists to attend the conference.